Drugs / CVD 1902
last change Apr 2013 re-read 3 minutes ago

CVD 1902

Vaccine

Developed for
salmonellosis
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID) · University of Maryland, Baltimore

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01129453 May 2010 → Dec 2012 salmonellosis University of Maryland, Baltimore Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CVD 1902 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01129453 ↗
Modality Vaccine “CVD 1902 (a live, attenuated, oral vaccine)” NCT01129453 ↗
Route Oral “Route: oral.” NCT01129453 ↗